Abstract
Both the innate and adaptive immune systems contribute to tumor immunosurveillance in mice and humans; however, there is a paucity of direct evidence of a role for natural killer (NK) cells in this important process. In this study, we investigated the intratumoral phenotypic profile and functions of NK cells in primary human tumor specimens of non-small cell lung carcinoma (NSCLC). We used in situ methods to quantify and localize NK cells using the NKp46 marker and we characterized their phenotype in blood, tumoral, and nontumoral samples of NSCLC patients. Intratumoral NK cells displayed a profound and coordinated alteration of their phenotype, with a drastic reduction of NK cell receptor expression specifically detected in the tumoral region. According to their altered phenotype, intratumoral NK cells exhibited profound defects in the ability to activate degranulation and IFN-γ production. We found that the presence of NK cells did not impact the clinical outcome of patients with NSCLC. Finally, we showed that tumor cells heterogeneously express ligands for both activating and inhibitory NK receptors. Taken together, our results suggest that the NSCLC tumor microenvironment locally impairs NK cells, rendering them less tumorcidal and thereby supportive to cancer progression.
Highlights
Lung cancer is one of the leading causes of cancer death and its incidence continues to increase worldwide [1]
We show that natural killer (NK) cells are enriched in non–small cell lung cancer (NSCLC) tumor microenvironment and localized in the stroma of the tumor
A strong reduction of receptors including NKp30, NKp80, CD16, DNAM-1, ILT-2, and KIR was observed on intratumoral NK cells whereas blood NK cells from the same patients displayed no significant modification of their phenotype as compared with healthy controls
Summary
Lung cancer is one of the leading causes of cancer death and its incidence continues to increase worldwide [1]. Innate and adaptive immune components infiltrate human lung tumors. A strong CD3þ T cell infiltration [2, 3] and several DC subsets were found in lung tumors. Despite the presence of an immune cell infiltrate, ineffective antitumor immunity is common in non–small cell lung cancer (NSCLC), and the correlation between tumor-infiltrating immune cells and the prognosis of patients with lung cancer remains controversial. Note: Supplementary data for this article are available at Cancer Research Online (http://cancerres.aacrjournals.org/). Authors' Affiliations: 1Institut National de la Sante et de la Recherche Medicale (INSERM), Centre de Recherche des Cordeliers; 2Universite Pierre et Marie Curie; 3Universite Paris Descartes; 4Services d'anatomopathologie et de chirurgie thoracique, Hôpital Hôtel Dieu; 5INSERM UMRS 945, Hôpital La Pitie-Salpetriere; 6Departement d'anatomo-pathologie, Institut Mutualiste Montsouris; 7Service d'Immunologie Biologique, Hôpital Europeen Georges Pompidou, Paris; and 8Innate Pharma, Marseille, France
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have